Search Results - "Peel, Michael R."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors by Stevens, Kirk L, Jung, David K, Alberti, Michael J, Badiang, Jennifer G, Peckham, Gregory E, Veal, Jim M, Cheung, Mui, Harris, Philip A, Chamberlain, Stanley D, Peel, Michael R

    Published in Organic letters (13-10-2005)
    “…A convergent synthesis of substituted pyrazolo[1,5-a]pyridines has been achieved either via a regioselective [3 + 2] cycloaddition of N-aminopyridines with…”
    Get full text
    Journal Article
  3. 3

    The identification of pyrazolo[1,5- a]pyridines as potent p38 kinase inhibitors by Cheung, Mui, Harris, Philip A., Badiang, Jennifer G., Peckham, Gregory E., Chamberlain, Stanley D., Alberti, Michael J., Jung, David K., Harris, Stephanie S., Bramson, Neal H., Epperly, Andrea H., Stimpson, Stephen A., Peel, Michael R.

    Published in Bioorganic & medicinal chemistry (15-10-2008)
    “…A series of pyrazolo[1,5- a]pyridine derivatives was designed and synthesized as novel potent p38 kinase inhibitors. Our approaches towards improving in vitro…”
    Get full text
    Journal Article
  4. 4

    A topical aqueous calcineurin inhibitor for the treatment of naturally occurring keratoconjunctivitis sicca in dogs by Gilger, Brian C., Wilkie, David A., Salmon, Jacklyn H., Peel, Michael R.

    Published in Veterinary ophthalmology (01-05-2013)
    “…Purpose  The purpose of this study was to evaluate the efficacy of an aqueous calcineurin inhibitor, SCY‐641, in the treatment of naturally occurring canine…”
    Get full text
    Journal Article
  5. 5

    Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors by Stevens, Kirk L., Reno, Michael J., Alberti, Jennifer B., Price, Daniel J., Kane-Carson, Laurie S., Knick, Victoria B., Shewchuk, Lisa M., Hassell, Anne M., Veal, James M., Davis, Stephen T., Griffin, Robert J., Peel, Michael R.

    Published in Bioorganic & medicinal chemistry (01-11-2008)
    “…A novel series of pyrazolo[1,5-b]pyridazines have been synthesized and identified as cyclin dependant kinase inhibitors potentially useful for the treatment of…”
    Get full text
    Journal Article
  6. 6

    The discovery of potent cRaf1 kinase inhibitors by LACKEY, K, CORY, M, RUTKOWSKE, R. D, VEAL, J. M, WOOD, E. R, DAVIS, R, FRYE, S. V, HARRIS, P. A, HUNTER, R. N, JUNG, D. K, MCDONALD, O. B, MCNUTT, R. W, PEEL, M. R

    Published in Bioorganic & medicinal chemistry letters (07-02-2000)
    “…A series of benzylidene-1H-indol-2-one (oxindole) derivatives was synthesized and evaluated as cRaf-1 kinase inhibitors. The key features of the molecules were…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Pyrazolo[1,5- a]pyridines: synthetic approaches to a novel class of antiherpetics by Johns, Brian A, Gudmundsson, Kristjan S, Turner, Elizabeth M, Allen, Scott H, Jung, David K, Sexton, Connie J, Boyd, F.Leslie, Peel, Michael R

    Published in Tetrahedron (03-11-2003)
    “…Synthesis of a novel class of 7-amino-3-pyrimidinyl-pyrazolo[1,5- a]pyridine antiherpetic compounds is described. The synthetic methodology is designed to…”
    Get full text
    Journal Article
  9. 9

    Peptide Ligands of pp60c-src SH2 Domains:  A Thermodynamic and Structural Study by Charifson, Paul S, Shewchuk, Lisa M, Rocque, Warren, Hummel, Conrad W, Jordan, Steven R, Mohr, Christopher, Pacofsky, Gregory J, Peel, Michael R, Rodriguez, Marc, Sternbach, Daniel D, Consler, Thomas G

    Published in Biochemistry (Easton) (27-05-1997)
    “…Thermodynamic measurements, structural determinations, and molecular computations were applied to a series of peptide ligands of the pp60c-src SH2 domain in an…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    The sexual abuse of men in detention in Sri Lanka by Peel, M, Mahtani, A, Hinshelwood, G, Forrest, D

    Published in The Lancet (British edition) (10-06-2000)
    “…Other difficulties for male rape victims are caused by common myths about male rape, for example, the belief that men cannot get an erection and ejaculate…”
    Get full text
    Journal Article
  13. 13

    Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study by Charifson, P S, Shewchuk, L M, Rocque, W, Hummel, C W, Jordan, S R, Mohr, C, Pacofsky, G J, Peel, M R, Rodriguez, M, Sternbach, D D, Consler, T G

    Published in Biochemistry (Easton) (27-05-1997)
    “…Thermodynamic measurements, structural determinations, and molecular computations were applied to a series of peptide ligands of the pp60(c-src) SH2 domain in…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effects on asylum seekers of ill treatment in Zaire by Peel, M R

    Published in BMJ (03-02-1996)
    “…To describe the health effects of the political system in Zaïre on asylum seekers seen at the Medical Foundation for the Care of Victims of Torture a…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Novel A-ring modified camptothecins as topoisomerase I inhibitors by Peel, Michael R., Milstead, Mark W., Sternbach, Daniel D., Besterman, Jeffrey M., Leitner, Peter, Morton, Bradley, Wall, Monroe E., Wani, Mansukh C.

    Published in Bioorganic & medicinal chemistry letters (21-09-1995)
    “…A camptothecin derivative has been prepared wherein the A-ring is fused to an oxazole ring. The compound was prepared via a Friedlander condensation involving…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity by Wood, E, Crosby, R M, Dickerson, S, Frye, S V, Griffin, R, Hunter, R, Jung, D K, McDonald, O B, McNutt, R, Mahony, W B, Peel, M R, Ray, J, Lackey, K

    Published in Anti-cancer drug design (01-02-2001)
    “…Earlier we reported potent cRaf1 kinase inhibitors with a key acidic phenol pharmacophore that had, at best, adequate cellular efficacy. To improve the…”
    Get more information
    Journal Article